IKT - Netong Asset Bawat Isang Bahagi Inhibikase Therapeutics Inc
Ang pag-aabang sa mga resulta ng Phase II trial para sa isang gamot sa sakit na Parkinson ay nagpapataas ng interes sa Inhibikase Therapeutics (IKT), kung saan ang kasalukuyang indicator ay nasa 1.16. Ang chart na ito ng kasalukuyang share price ay sumasalamin sa dynamics ng kumpanya, na bumubuo ng isang neurodegeneration therapy system sa pamamagitan ng mga kinase inhibitor. Ang negosyo ay nakasalalay sa precision delivery ng mga biomaterials, habang ang isang partnership sa isang laboratory network ay nagsisiguro ng katatagan ng supply at mataas na profitability.
Mga analytical breakdown ng kumpanyang inhibikase.com (IKT)
- presyo ng share at pagtataya ng presyo ng mga eksperto:
- estadistika ng market capitalization:
- datos ng book value ng stockholders' equity:
- mga indicator ng pasanin sa utang at liquidity:
Utang sa Stockholders Equity Inhibikase Therapeutics|IKT - Coefficient ng pangmatagalang utang sa kapital|Panandaliang utang sa equity Inhibikase Therapeutics, Inc.|IKT - Kabuuang halaga ng utang ng kumpanya|Mga utang sa book capitalization Inhibikase Therapeutics, Inc.|IKT - Laki ng pangmatagalang utang|Panandaliang utang ng kumpanya Inhibikase Therapeutics|Quick Ratio inhibikase.com
- mga indicator ng net income at valuation multiples:
Pangunahing pagsusuri ng kumpanya:Inhibikase (IKT)
Ang book value per share ay sumasalamin sa net equity ng kumpanya minus lahat ng liabilities, na nagpapahintulot sa aggregate book value per security na tukuyin ang fundamental basis ng asset sa panahon ng market volatility. Para sa Inhibikase Therapeutics (IKT), ang kalkuladong indicator na ito ay nagpapakita ng aktwal na tangible backing ng bawat share, na kritikal kapag sinusuri ang halaga ng isang highly specialized scientific staff at mga long-term researcher option programs.
Mga kakumpitensya ng Inhibikase Therapeutics
BIIB: Accounting Book Value Bawat Bahagi|Neurocrine Corp - Book Price ng Bahagi|Regencell Bioscience (RGC) - Netong Asset Bawat Isang Bahagi|Stockholders Equity Bawat Bahagi AXSM|ACAD (ACADIA Pharmaceuticals Inc.) - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Xenon Pharmaceuticals Inc. XENE|Accounting Book Value Bawat Bahagi VKTX (Viking Pharma)|Book Value Bawat Bahagi Supernus Corp (SUPN)|Netong Asset Bawat Isang Bahagi Catalyst Pharmaceuticals CPRX|Accounting Value ng Bahagi DNLI|HRMY - Netong Asset Bawat Isang Bahagi|Net Asset Value Bawat Bahagi Biohaven Ltd|AMLX: Book Value Bawat Bahagi|TRVI - Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi Praxis Precision Medicines|Stockholders Equity Bawat Bahagi AVXL (anavex.com)|Book Value Bawat Bahagi CBLL|PRTA (Prothena Corporation) - Accounting Value ng Bahagi|Book Value Bawat Bahagi ALEC (Alector)|Net Assets Bawat Bahagi Annexon Biosciences Inc. (ANNX)|Omeros Corp. - Book Value Bawat Bahagi|NGNE: Netong Asset Bawat Isang Bahagi|ACIU: Book Value Bawat Bahagi|VYGR - Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi Neumora Therapeutics Inc|Book Value Bawat Bahagi Scilex Holding Company, Inc.|Book Value Bawat Bahagi TVGN|Book Value Bawat Bahagi alphacognition.com (ACOG)|Netong Asset Bawat Isang Bahagi Cognition Therapeutics CGTX|Net Assets Bawat Bahagi Cassava Sciences Inc (SAVA)|Assertio Therapeutics - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Coya Therapeutics, Inc.|VTGN (vistagen.com) - Accounting Book Value Bawat Bahagi|Ovid Therapeutics - Accounting Value ng Bahagi|Accounting Book Value Bawat Bahagi ABOS|CRVO (CervoMed, Inc.) - Book Price ng Bahagi|Book Value Bawat Bahagi ATHE|CLNN (clene.com) - Accounting Value ng Bahagi|Book Value Bawat Bahagi PEPG (PepGen)|Jupiter Neurosciences, Inc. (JUNS) - Net Asset Value Bawat Bahagi|RLMD - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi ANVS (Annovis Bio Inc)|GRCE: Book Value Bawat Bahagi|Firefly Neuro (AIFF) - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi ANEW Medical|NeuroSense Therapeutics, Ltd. - Book Value ng Bahagi|Book Value Bawat Bahagi RVPH|MTVA - Net Asset Value Bawat Bahagi|NeurAxis, Inc - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi Helius Medical Technologies, Inc. HSDT|PASG: Accounting Book Value Bawat Bahagi|Neuphoria Therapeutics Inc. - Book Price ng Bahagi|NERV: Book Value Bawat Bahagi|ATHA - Net Assets Bawat Bahagi|ADXN (Addex Therapeutics, Ltd.) - Book Value Bawat Bahagi|Accounting Book Value Bawat Bahagi Alzamend (ALZN)|Netong Asset Bawat Isang Bahagi Cyclerion Therapeutics (CYCN)|Net Assets Bawat Bahagi protagenic.com|Book Value Bawat Bahagi KTTA (Pasithea Therapeutics Corp.)|Net Assets Bawat Bahagi Cortigent Inc (CRGT)|ATXI - Netong Asset Bawat Isang Bahagi|BCLI - Book Value Bawat Bahagi|CARA (Cara Therapeutics, Inc.) - Accounting Book Value Bawat Bahagi|CHRO: Book Price ng Bahagi|Netong Asset Bawat Isang Bahagi Eliem Therapeutics, Inc.|Stockholders Equity Bawat Bahagi ITCI (Intra-Cellular)|Book Value Bawat Bahagi LBPH|MRNS - Net Asset Value Bawat Bahagi|NKGen Biotech, Inc. - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi neurobopharma.com NRBO|SAGE - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi SNPX (Synaptogenix Inc.)|Trevena, Inc (TRVN) - Netong Asset Bawat Isang Bahagi|Net Asset Value Bawat Bahagi Vigil Neuroscience, Inc. (VIGL)|WENA (Anew Medical) - Book Value Bawat Bahagi|cerevel.com (CERE) - Net Assets Bawat Bahagi